Searchable abstracts of presentations at key conferences in endocrinology

ea0089b6 | Basic Science | NANETS2022

Detecting Cell Surface Expression of Calreticulin in Pancreatic Neuroendocrine Tumors Using a Novel [68Ga]-Radiolabeled Peptide

Guenter Rachael , Ducharme Maxwell , Herring Brendon , Montes Odalyz , McCaw Tyler , Lee Goo , Dhall Deepti , MacVicar Caroline , Chen Herbert , Lapi Suzanne E. , Larimer Benjamin , Bart Rose J.

Background: Current theragnostic techniques for pancreatic neuroendocrine tumors (pNETs) exploit the overexpression of somatostatin receptors (SSTRs) on the cell surface. However, approximately 25% of low-grade and most high-grade pNETs do not express SSTRs, requiring alternative theranostics. Calreticulin (CALR) is a protein linked to reticular calcium homeostasis and immunogenic cell death. Upon sufficient cellular insult, CALR translocates from the endoplasmic reticulum (ER...

ea0089c39 | Clinical – Surgery/Applied Pathology | NANETS2022

Have We Accounted for Asians? A Critical Analysis of Racial Cancer Disparity Amongst Asian Pancreatic Neuroendocrine Tumor Patients

E McElroy, MD Katherine , Irfan, MD Ahmer , Reddy, MD Sushanth , Yates, PhD Clayton , Chen, MD, FACS Herbert , Bart Rose, MD J.

Background: Pancreatic neuroendocrine tumors (pNETs) are slow growing, malignant tumors that show different survival outcomes by race. They are often diagnosed in late stages, with few treatments available. PNETs are the second most common pancreatic cancer and are rapidly increasing in incidence. Current size-based guidelines were largely developed in White patients and recently have been called into question for Black patients. We investigated differences of primary tumor si...

ea0063gp25 | Calcium and Bone 1 | ECE2019

Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey

Bollerslev Jens , Bent-Ennakhil Nawal , Chen Kristina , Clarke Bart L , Dahl-Hansen Helen , Germak John , Gibson Katie , Glenister Elizabeth , Judge Davneet , Marelli Claudio , Siggelkow Heide

Significant knowledge gaps exist regarding the humanistic effects of hypoparathyroidism, a rare, debilitating disorder. We report results from a global survey to characterise the burden of hypoparathyroidism from the patient perspective. An anonymous survey was conducted in patients with uncontrolled chronic hypoparathyroidism (as determined by patients’ report of persistent symptoms and/or poorly controlled calcium levels as told by their physician) despite receiving con...

ea0063gp148 | Interdisciplinary Endocrinology 1 | ECE2019

Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

Chen Kristina , Kaul Sanjiv , Curhan Gary , Gosmanova Elvira O. , Mu Fan , Swallow Elyse , Briggs Allison , Sherry Nicole , Ketteler Markus , Rejnmark Lars

Background: Prior small studies have suggested increased risk of cardiovascular (CV) conditions in patients with hypoparathyroidism (HypoPT). We evaluated whether chronic HypoPT is associated with increased risk of select CV hard endpoints (i.e., myocardial infarction (MI), stroke, and a composite CV endpoint) in a large contemporary cohort.Methods: A retrospective cohort study, based on a US commercial claims database (Q1 2007 - Q2 2017), was conducted ...

ea0063p207 | Diabetes, Obesity and Metabolism 1 | ECE2019

An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany

Chen Jieling , Perez-Nieves Magaly , De Oliveira Carolina Piras , Spaepen Erik , Osumili Beatrice , Poon Jiat Ling , Schloot Nanette , Lara Nuria , Alvarez Laura Garcia , Roset Montserrat , Lennartz Dirk

Background: Insulin Lispro 200 units/ml is a concentrated rapid-acting mealtime insulin (MTI) available as a prefilled, disposable pen (IL200) indicated for adults who require >20 units/day of prandial insulin. In comparison with Insulin Lispro 100 unit/ml prefilled pen, IL200 permits the delivery of an insulin dose in half the injection volume [1] and a lower glide force [2]. This study aims to understand physicians’ reasons to prescribe IL200, as well as characteriz...

ea0063ep19 | Adrenal and Neuroendocrine Tumours | ECE2019

ACTH-Producing neuroendocrine cancer of the thymus with pancreatic metastasis, presenting with flush

Chang Ling-Kai , Wu Jer-Wei , Hsu Chia-Lin , Lin Chia-Chi , Cheng Mei-Fang , Chen Rou-He , Wang Hsiu-Po , Shih Shyang-Rong

Context: ACTH-producing neuroendocrine cancer (NEC) of the thymus is rare. Lymph nodes and bone are most common metastatic sites. ACTH-secreting thymic NEC with pancreatic metastasis was only reported in one case. Most cases presented with florid Cushing syndrome (CS). Our case had thymic NEC with pancreatic metastasis, presenting with intermittent flush instead of typical CS. We demonstrate the comprehensive information of somatostatin receptors (SSTR), three different kinds ...

ea0049oc4.2 | Thyroid Disease 1 | ECE2017

Inducible thyrocyte-specific Gs alpha-deficient mice as a novel model for hypothyroidism

Patyra Konrad , Jaeschke Holger , Undeutsch Henriette , Lof Christoffer , Ruohonen Suvi , Jannari Meeri , Chen Min , Weinstein Lee S. , Paschke Ralf , Toppari Jorma , Kero Jukka

The thyroid gland produces thyroid hormones, which are essential regulators of growth, development and metabolism of the body and is mainly regulated by the thyroid stimulating hormone (TSH)/TSH receptor (TSHR) interplay. The TSHR couples to all four G protein families in vitro but only for the Gs and Gq signaling cascade a role has been identified in vivo. To gain further insights into the complex signaling networks mediated by G proteins in the thyroid, we generated...

ea0037ep800 | Pituitary: clinical | ECE2015

Metformin-based oral antidiabetic therapy proved effective in hyperglycaemia associated with pasireotide in patients with acromegaly

Colao Anna Maria , Gu Feng , Gadelha Monica R , Lely Aart J van der , Fleseriu Maria , Passos Vanessa , Ravichandran Shoba , Chen Yin Miao , Bronstein Marcello D

Introduction: High affinity binding of pasireotide for both sst2 and sst5 leads to its enhanced efficacy in treatment of acromegaly but results in decreased secretion of insulin, incretins (GLP-1 and GIP) and, to a lesser extent, glucagon. Metformin may be a good option in patients with acromegaly experiencing hyperglycaemia with pasireotide as it improves GLP-1 secretion. We analysed data from a 12-month, Phase III, randomised study in medically naï...

ea0035p736 | Nuclear receptors and signal transduction | ECE2014

Formation of progesterone receptor-NF-κB complex is required for progesterone-induced NF-κB nuclear translocation and binding onto the p53 promoter

Hsu Sung-Po , Yang Ho-Ching , Kuo Chun-Ting , Wen Heng-Ching , Chen Li-Ching , Huo Yen-Nien , Lee Wen-Sen

We previously showed that progesterone (P4) regulates p53 expression and cell cycle progress in human umbilical venous endothelial cells (HUVEC) through progesterone receptor (PR) activation of extra-nuclear signaling pathways. Here, we showed that P4 activated the PR and hence increased the formation of progesterone receptor A-(PR-A)-NF-κB complex in both the cytosol and the nucleus. Chromatin immunoprecipitation demonstrated an interaction between PR and the NF-κB ...

ea0035p748 | Obesity | ECE2014

Bariatric surgery and bone loss: novel mechanisms and comparison of different modalities

Brzozowska Malgorzata , Bliuc Dana , Hong Angel , Jorgensen John , Talbot Michael , Rigas Georgia , Chen Weiwen , Pocock Nicholas , Eisman John , White Christopher , Baldock Paul , Center Jacqueline

Although bariatric surgery is the most effective weight loss therapy, its skeletal consequences are unclear. The aim of this study was to assess the impact of weight loss, gut hormones, adiponectin on bone loss in people undergoing Dieting (Diet), Gastric Banding (GB) and Gastric Sleeve (GS) over 24 months post-intervention.There were 15 Diet, 8 GB and 20 GS subjects with mean (±S.D.) age 53 (12) years and BMI 39 (6). At 12 months mea...